RGS7BP

RGS7BP (R7BP) is a neuronally expressed, palmitoylated membrane anchor that organizes the subcellular localization, stability, and signaling output of R7-family RGS protein complexes that accelerate Gi/o GTPase activity at GPCRs (PMID:15632198, PMID:15897264). It forms tight complexes with all four R7 RGS proteins (RGS6, RGS7, RGS9, RGS11) and Gβ5, binding through an interface formed by the RGS DEP and R7H domains contacting the R7BP core (PMID:15632198, PMID:17158100), with crystallography and cross-linking mass spectrometry resolving the synergistic intermolecular interfaces of the RGS7–Gβ5–R7BP heterotrimer and its allosteric conformational coupling (PMID:30540250, PMID:31531399). C-terminal palmitoylation, acting together with an adjacent polybasic motif, targets these complexes to the plasma membrane and postsynaptic density, and only the membrane-bound, palmitoylated form efficiently augments RGS-mediated attenuation of GPCR–GIRK channel signaling; depalmitoylation exposes nuclear localization sequences and drives nuclear/cytoplasmic shuttling of the complex (PMID:15897264, PMID:16867977, PMID:16574655). Beyond localization, R7BP stabilizes its RGS partners post-translationally by shielding RGS9-2 degradation determinants from lysosomal cysteine proteases (PMID:17158100, PMID:18094251), and the complex undergoes activity-dependent remodeling in which calcium entry uncouples RGS9-2 (triggering its degradation) and frees R7BP to recruit RGS7 to the membrane (PMID:19332565). Functionally, R7BP sets the dynamic range and kinetics of GABAB receptor–GIRK responses in hippocampal and cerebellar neurons (PMID:24755289, PMID:27965545), shapes striatal dopamine/opioid behaviors (PMID:20043004), and is required for normal itch sensation acting upstream of kappa-opioid receptor signaling (PMID:28134655).

1. 2005 High

   Established that R7BP is a dedicated binding partner for the entire R7 RGS subfamily, defining the molecular basis of complex assembly via the RGS DEP domain.

   Evidence Reciprocal Co-IP from striatal brain extracts plus in vitro binding with recombinant proteins

   PMID:15632198

   Open questions at the time

   • Did not resolve which residues of the R7BP core mediate binding
   • Functional consequence of complex formation not yet tested
2. 2005 High

   Showed that palmitoylation controls membrane targeting and signaling potency, answering how R7BP enhances RGS-mediated GPCR regulation and revealing a depalmitoylation-driven nuclear shuttling switch.

   Evidence Live-cell imaging, palmitoylation assays, and GIRK channel electrophysiology

   PMID:15897264

   Open questions at the time

   • Enzymes catalyzing palmitoylation/depalmitoylation not identified
   • Physiological trigger for depalmitoylation unknown at this stage
3. 2006 High

   Defined the C-terminal polybasic motif and palmitoylated cysteines as the bipartite signal whose synergy dictates plasma membrane versus nuclear localization and the necessity of membrane localization for signaling.

   Evidence Site-directed mutagenesis with localization and GIRK signaling assays in striatal neurons

   PMID:16574655 PMID:16867977

   Open questions at the time

   • Structural basis of polybasic motif recognition unresolved
   • Nuclear function of the shuttled complex undefined
4. 2006 High

   Revealed that R7BP is not only a localizer but a stabilizer, controlling RGS9-2 abundance by protecting it from proteolysis, and mapped the DEP/R7H–core binding interface.

   Evidence Co-expression degradation kinetics, lentiviral RNAi in native striatal neurons, domain mapping

   PMID:17158100

   Open questions at the time

   • Identity of the degradation pathway not yet pinpointed at this stage
   • Whether stabilization applies equally to other R7 partners untested
5. 2007 High

   Identified the lysosomal cysteine protease pathway as the route of RGS9-2 turnover shielded by R7BP and placed the complex at the postsynaptic density in vivo during development.

   Evidence In vivo biochemistry, protease inhibitor studies, immunoelectron microscopy, developmental profiling

   PMID:18094251

   Open questions at the time

   • Specific protease(s) not molecularly identified
   • Mechanism coupling synaptic demand to complex accumulation unclear
6. 2007 Medium

   Demonstrated compartment- and tissue-specific anchor usage, distinguishing R7BP-associated R7 complexes in retinal synapses from R9AP-associated complexes in photoreceptors.

   Evidence Co-IP, immunolocalization, and knockout mouse analysis in retina; recruitment and IHC in brain and Neuro2A cells

   PMID:17442586 PMID:18248908

   Open questions at the time

   • Determinants selecting R7BP versus R9AP not defined
   • Single-lab localization findings without orthogonal confirmation
7. 2008 Medium

   Showed that RGS7/Gβ5 targeting to retinal ON-bipolar dendritic tips is R7BP-independent, establishing that not all R7 complex localization requires this anchor.

   Evidence Immunolocalization in R7BP knockout mice

   PMID:18842904

   Open questions at the time

   • Alternative targeting adapter for this complex unidentified
   • Single readout per conclusion
8. 2009 Medium

   Uncovered activity-dependent partner remodeling, showing calcium influx uncouples RGS9-2 from R7BP and redirects R7BP to RGS7, linking neuronal activity to RGS complex composition.

   Evidence Co-IP and fractionation from striatal tissue under defined stimulation conditions

   PMID:19332565

   Open questions at the time

   • Molecular sensor coupling calcium to uncoupling unknown
   • Single-lab biochemistry without in vivo validation
9. 2009 Medium

   Quantified R7BP binding preferences among purified partners and identified a direct Gαoa–R7BP interaction, extending the interaction map beyond RGS/Gβ5.

   Evidence In vitro binding assays with purified recombinant proteins measuring dissociation constants

   PMID:19497306

   Open questions at the time

   • Physiological relevance of direct Gαoa–R7BP binding untested in cells
   • Single in vitro study
10. 2009 Medium

    Established physiological consequences in striatum, showing R7BP-dependent balance of RGS9-2 and RGS7 governs motor coordination and drug-evoked locomotor behaviors.

    Evidence Knockout mouse behavior and striatum-specific lentiviral knockdown with biochemical quantification

    PMID:20043004

    Open questions at the time

    • Circuit-level signaling changes not directly recorded
    • Receptor partners driving each behavior not fully resolved
11. 2014 High

    Demonstrated that R7BP sets the dynamic range and kinetics of GABAB receptor–GIRK signaling in hippocampal neurons, defining its role in synaptic inhibition.

    Evidence Electrophysiology in R7BP knockout hippocampal pyramidal neurons

    PMID:24755289

    Open questions at the time

    • Contribution to behavioral plasticity not directly tested here
    • Whether other GPCRs share this regulation unaddressed
12. 2016 Medium

    Confirmed R7BP-dependent membrane targeting of RGS7/Gβ5 at cerebellar Purkinje cell synapses, generalizing its anchoring role across brain regions.

    Evidence Co-IP, immunohistochemistry, and electron microscopy in R7BP knockout mice

    PMID:27965545

    Open questions at the time

    • Functional signaling consequence in cerebellum not measured
    • Pre- versus postsynaptic functional roles undistinguished
13. 2017 High

    Placed R7BP-dependent GAP activity in a sensory pathway, showing it is required for itch and acts upstream of kappa-opioid receptor-mediated itch inhibition.

    Evidence Knockout mouse behavioral assays with R7BP/Oprk1 double-knockout epistasis and pharmacological challenge

    PMID:28134655

    Open questions at the time

    • Cell type and circuit mediating itch effect not defined
    • Which R7 RGS partner mediates the effect not specified
14. 2018 High

    Resolved the atomic architecture of the RGS7–Gβ5–R7BP complex, revealing synergistic interfaces and long-range allosteric coupling among subunits.

    Evidence X-ray crystallography with molecular dynamics and mass spectrometry

    PMID:30540250

    Open questions at the time

    • Structure of the palmitoylated, membrane-bound state not captured
    • Conformational basis of GAP enhancement not directly visualized
15. 2019 Medium

    Mapped the R7BP–RGS7/Gβ5 interaction interfaces and produced antibody and dominant-negative tools to inhibit the complex, enabling targeted disruption.

    Evidence Cross-linking mass spectrometry, integrated modeling, surface plasmon resonance, dominant-negative construct

    PMID:31531399

    Open questions at the time

    • In vivo efficacy of inhibitors not demonstrated
    • Specificity across R7 family members not fully resolved

• How activity-dependent palmitoylation/depalmitoylation cycling and partner remodeling are enzymatically controlled, and what the depalmitoylated nuclear complex does, remain unresolved.
• Palmitoyl acyltransferase/thioesterase for R7BP unidentified
• Function of nuclear R7BP–R7–Gβ5 complex unknown
• Calcium sensor driving RGS9-2/RGS7 switching uncharacterized